Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	289,515	203,202	-	-	-	-
Enterprise Value	302,401	214,615	-	-	-	-
Last Close Price	1527.20	1070.19	-	-	-	-
PE Ratio	36.47	29.82	-	-	-	-
Forward PE	28.01	24.17	-	-	-	-
PS Ratio	3.43	2.57	-	-	-	-
PB Ratio	5.93	4.38	-	-	-	-
P/TBV Ratio	7.76	5.81	-	-	-	-
P/FCF Ratio	57.07	32.26	-	-	-	-
P/OCF Ratio	38.72	23.86	-	-	-	-
PEG Ratio	1.08	0.93	-	-	-	-
EV/Sales Ratio	3.58	2.72	-	-	-	-
EV/EBITDA Ratio	19.08	15.20	-	-	-	-
EV/EBIT Ratio	25.26	19.79	-	-	-	-
EV/FCF Ratio	59.61	34.07	-	-	-	-
Debt / Equity Ratio	0.34	0.22	0.75	0.88	1.05	1.04
Debt / EBITDA Ratio	1.05	0.70	1.91	1.99	1.68	1.93
Debt / FCF Ratio	3.27	1.62	2.84	6.55	5.69	4.26
Asset Turnover	0.97	0.99	0.92	0.94	0.91	0.79
Inventory Turnover	1.70	1.80	1.66	1.54	1.47	1.39
Quick Ratio	0.79	0.86	0.75	0.72	0.51	0.58
Current Ratio	1.52	1.71	1.33	1.27	1.16	1.09
Return on Equity (ROE)	17.84%	18.23%	18.28%	23.59%	31.35%	27.90%
Return on Assets (ROA)	8.54%	8.45%	7.92%	9.04%	10.54%	9.43%
Return on Capital (ROIC)	12.43%	12.19%	10.98%	12.36%	14.80%	13.20%
Return on Capital Employed (ROCE)	21.00%	19.50%	20.00%	25.20%	35.00%	28.40%
Earnings Yield	2.74%	3.35%	-	-	-	-
FCF Yield	1.75%	3.10%	-	-	-	-
Dividend Yield	0.20%	0.28%	-	-	-	-
Payout Ratio	7.17%	-	10.89%	6.80%	8.19%	4.61%
Buyback Yield / Dilution	-3.59%	-3.41%	-0.01%	-	-	-
Total Shareholder Return	-3.39%	-3.13%	-0.01%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.